Literature DB >> 7267134

Adjuvant-induced arthritis in rats: a possible animal model of chronic pain.

M De Castro Costa, P De Sutter, J Gybels, J Van Hees.   

Abstract

Adjuvant-induced arthritic rats were observed clinically and behaviorally. The clinical disease has a duration of greater than 1 month and can be divided into a pre-clinical (1-10 days), an acute (15-30 days), postacute (30-50 days) and a late phase (greater than 50 days). Adjuvant arthritis induces significantly quantitatively changes in the rats' behaviour. Two types of behavioural change merit special attention: freezing (arresting) and scratching. Freezing is significantly increased in the acute and postacute phases; it is increased by morphine, this effect being blocked by naloxone. Scratching is significantly increased in the acute, postacute and late phases; it is decreased by morphine, this effect being blocked by naloxone. The chronic presence of scratching, and the effects of morphine and naloxone on it, allow us to consider it as a possible pain-rated behaviour and therefore as a possible parameter for the study of chronic pain in animals.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7267134     DOI: 10.1016/0304-3959(81)90193-7

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  28 in total

1.  Modifications of serotonin-, substance P- and calcitonin gene-related peptide-like immunoreactivities in the dorsal horn of the spinal cord of arthritic rats: a quantitative immunocytochemical study.

Authors:  L Marlier; P Poulat; N Rajaofetra; A Privat
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  Inhibitory effects of andrographolide on activated macrophages and adjuvant-induced arthritis.

Authors:  Swati Gupta; Kamla Prasad Mishra; Shashi Bala Singh; Lilly Ganju
Journal:  Inflammopharmacology       Date:  2017-07-22       Impact factor: 4.473

3.  The effect of lysine acetylsalicylate on joint capsule mechanoreceptors in rats with polyarthritis.

Authors:  G Guilbaud; A Iggo
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

4.  Sensory receptors in ankle joint capsules of normal and arthritic rats.

Authors:  G Guilbaud; A Iggo; R Tegnér
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

5.  Artesunate Ameliorates Functional Limitations in Freund's Complete Adjuvant-Induced Monoarthritis in Rat by Maintaining Oxidative Homeostasis and Inhibiting COX-2 Expression.

Authors:  B Guruprasad; Priyanka Chaudhary; Tenzin Choedon; Vijay L Kumar
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

6.  Increased calcitonin gene-related peptide (CGRP), substance P, and enkephalin immunoreactivities in dorsal spinal cord and loss of CGRP-immunoreactive motoneurons in arthritic rats depend on intact peripheral nerve supply.

Authors:  S Kar; S J Gibson; R G Rees; W G Jura; D A Brewerton; J M Polak
Journal:  J Mol Neurosci       Date:  1991       Impact factor: 3.444

7.  Effects of long term polyarthritis and subsequent NSAID treatment on activity with disassociation of tactile allodynia in the mouse.

Authors:  Mohammed S A Suhail; Christina Christianson; Fred Koehrn; Shelle A Malkmus; William Mitchell; Maripat Corr; Tony L Yaksh
Journal:  Neurocomputing       Date:  2011-12-31       Impact factor: 5.719

8.  Chronic pain is associated with increased TrkA immunoreactivity in spinoreticular neurons.

Authors:  S Pezet; B Onténiente; G Grannec; B Calvino
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

9.  Spinal substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states.

Authors:  P Honor; P M Menning; S D Rogers; M L Nichols; A I Basbaum; J M Besson; P W Mantyh
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

10.  Antinociceptive effects of neonatal capsaicin in rats with adjuvant arthritis.

Authors:  A Hara; T Sakurada; S Sakurada; H Matsumura; K Kisara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.